SuRo Capital Corp. Second Quarter 2020 Preliminary Investment Portfolio Update
SAN FRANCISCO, July 02, 2020 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq:SSSS) today provided the […]
BRP Group, Inc. Appoints Erin King as Chief Colleague Officer
TAMPA, Fla., July 02, 2020 (GLOBE NEWSWIRE) — BRP Group, Inc. (“BRP Group”) (NASDAQ: BRP), a rapidly growing independent insurance […]
TSX News -
BRP to Increase Manufacturing Capacity in Mexico to Meet Side-by-Side Vehicles Demand
VALCOURT, Quebec, July 02, 2020 (GLOBE NEWSWIRE) — BRP (TSX: DOO; NASDAQ: DOOO) announced today that it is increasing its […]
Award Winning Canadian Journalist & News Anchor Gord Martineau joins ARHT Media in Advisory Role
TORONTO, July 02, 2020 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), is the global leader in […]
Full House Resorts Announces Two New Appointments to Its Board of Directors
LAS VEGAS, July 02, 2020 (GLOBE NEWSWIRE) — Full House Resorts (Nasdaq: FLL) announced today that it has appointed Eric […]
Cannabis Sativa, Inc. Reports Record First Quarter Revenues
Mesquite, NV, July 02, 2020 (GLOBE NEWSWIRE) — MESQUITE, NV / July 2, 2020 / Cannabis Sativa, Inc. (OTCQB:CBDS) reported record […]
WeedMD Announces Amendments to Existing Credit Facility
TORONTO, July 02, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 02, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]
ABM Establishes Expert Advisory Council to Support COVID-19 Response and EnhancedClean™ Program
NEW YORK, July 02, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announces that it […]
Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
PRINCE study enrolled 53 patients. Trial designed to further establish the potential of pegcetacoplan, a targeted C3 therapy, in all […]
